Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
When do you consider disease modifying therapy in radiographically isolated syndrome?
Does reclassification of RIS as MS in upcoming McDonald Criteria change this decision for you?
Related Questions
When would you use ofatumumab for anti-NMDAR autoimmune encephalitis?
How do you counsel women on anti-CD20 therapy for MS who are planning for pregnancy?
What are your preferred treatments for relapsing remitting multiple sclerosis with comorbid IBD?
Would a longstanding diagnosis of multiple sclerosis impact your radiation recommendations for a patient with breast cancer?
Do you have any clinical experience regarding the administration of B cell depleting therapies in MS patients with splenectomy?
What is the role of skin biopsy for evaluating small fiber neuropathy in patients with rheumatic disease who have treatment recalcitrant pain?
Do you consider steroid-sparing agents for treatment of patients with steroid responsive relapsed Hashimoto Encephalopathy?
When do you suspect an autoimmune encephalitis in a child or adolescent with new-onset psychosis?
when do you treat suspected autoimmune encephalitis before antibody results?
What are your vaccine recommendations while patients are on biologics?